Medigene to present first pre-clinical data for MDG1015
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the......
2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness,......
LanzaTech (LNZA) Announces New Board Members to Accelerate
New directors bring diverse wealth of experience across sustainable development, corporate finance, and social impact sectors to bolster company’s vision......
Alvotech Announces Webcast of 2022 Full Year Financial
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced......
Alvotech enters into commercialization agreement with
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia,......
Surface Oncology to Participate in the 2023 Guggenheim
CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......
Premiere Synthetic Biology Event on Track for Record
SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO,......